Drug giant Pfizer has combined operations with Wyeth, following the closure of a $68 billion acquisition last week. The deal included its subsidiary Fort Dodge Animal Health, which is now part of Pfizer Animal Health.
Pfizer Animal Health, one of six business units of Pfizer, is a world leader in discovering and developing innovative animal prescription medicines and vaccines, investing $300 million annually.
The acquisition of Fort Dodge U.S. products will allow Pfizer Animal Health to expand its U.S. portfolio, as well as broaden its offerings within all animal health divisions.
“We are proud to offer our customers even more best-in-class and innovative products,” said Clint Lewis, president of U.S. Operations for Pfizer Animal Health. “Our products, services and expertise will expand what is already a robust U.S. portfolio while enhancing our position in the animal health marketplace.
An overview of Pfizer Animal Health’s U.S. product portfolio.
“Pfizer Animal Health is dedicated to working alongside our customers and partners to transform the care, health and well-being of animals,” Mr. Lewis said. “We will continue to envision a future where animal health care providers, veterinarians and livestock producers turn to Pfizer to help them to run their practice or operation productively and profitably. Pfizer is more focused than ever on providing relevant solutions to their animal care needs,” Mr. Lewis said.
Veterinarians and their customers in more than 60 countries across four global regions - United States; Europe, Africa & the Middle East; Canada & Latin America; and Asia Pacific, are supported by Pfizer Animal Health.
Fort Dodge Animal Health
Fort Dodge Animal Health is a leading manufacturer and marketer of animal products for the livestock companion animal, equine, swine and poultry industries in North America and international markets. The company has research and development facilities in Iowa and New Jersey, and manufacturing facilities/offices in several countries. #